PH23189A - 2-pyrrolidone derivative - Google Patents

2-pyrrolidone derivative

Info

Publication number
PH23189A
PH23189A PH33721A PH33721A PH23189A PH 23189 A PH23189 A PH 23189A PH 33721 A PH33721 A PH 33721A PH 33721 A PH33721 A PH 33721A PH 23189 A PH23189 A PH 23189A
Authority
PH
Philippines
Prior art keywords
alkylene
pyrrolidone derivative
pyrrolidone
hydroxy
derivative
Prior art date
Application number
PH33721A
Other languages
English (en)
Inventor
Hironori Ikuta
Youji Yamagishi
Kozo Akasaka
Isao Yamatsu
Seiichi Kobayashi
Hiroshi Shirota
Kouichi Katayama
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of PH23189A publication Critical patent/PH23189A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/38—2-Pyrrolones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/50—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PH33721A 1985-05-09 1986-04-30 2-pyrrolidone derivative PH23189A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60096799A JPH066571B2 (ja) 1985-05-09 1985-05-09 ２−ピロリドン誘導体

Publications (1)

Publication Number Publication Date
PH23189A true PH23189A (en) 1989-05-29

Family

ID=14174668

Family Applications (2)

Application Number Title Priority Date Filing Date
PH33721A PH23189A (en) 1985-05-09 1986-04-30 2-pyrrolidone derivative
PH35306A PH23225A (en) 1985-05-09 1987-05-27 2-pyrrolidone derivative

Family Applications After (1)

Application Number Title Priority Date Filing Date
PH35306A PH23225A (en) 1985-05-09 1987-05-27 2-pyrrolidone derivative

Country Status (19)

Country Link
US (1) US4833160A (zh)
EP (1) EP0204964B1 (zh)
JP (1) JPH066571B2 (zh)
KR (1) KR910004789B1 (zh)
CN (1) CN1014058B (zh)
AT (1) ATE66673T1 (zh)
AU (1) AU581078B2 (zh)
CA (1) CA1264762A (zh)
DE (1) DE3681076D1 (zh)
DK (1) DK213286A (zh)
ES (1) ES8800148A1 (zh)
FI (1) FI84172C (zh)
HU (2) HU199117B (zh)
MX (1) MX162717A (zh)
NO (1) NO861820L (zh)
NZ (1) NZ216092A (zh)
PH (2) PH23189A (zh)
PT (1) PT82540B (zh)
ZA (1) ZA863352B (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5691367A (en) * 1985-08-09 1997-11-25 Eli Lilly And Company Aryl-substituted rhodanine derivatives
US5356917A (en) * 1985-08-09 1994-10-18 Eli Lilly And Company Aryl-substituted rhodanine derivatives
DE3874257T2 (de) * 1987-03-11 1993-02-11 Kanegafuchi Chemical Ind Hydroxystyren-derivate.
US5202341A (en) * 1987-03-11 1993-04-13 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Hydroxystyrene compounds having tyrosine kinase inhibiting activity
US5089516A (en) * 1987-03-11 1992-02-18 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha 1-phenyl-3,5-pyrazolidinedione hydroxystyrene compounds which have tyrosine kinase inhibiting activity
US5216002A (en) * 1989-12-21 1993-06-01 Eli Lilly And Company Method of treating inflammatory bowel disease
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
US5319099A (en) * 1991-01-21 1994-06-07 Shionogi Seiyaku Kabushiki Kaisha 3-benzylidene-1-carbamoyl-2-pyrrolidone compounds useful as antiinflammatory agents
JP3150695B2 (ja) * 1991-04-05 2001-03-26 鐘淵化学工業株式会社 フェノキシベンゼン誘導体
EP0595546B1 (en) * 1992-10-28 1996-03-20 Shionogi & Co., Ltd. Benzylidene derivatives
US5358964A (en) * 1993-07-26 1994-10-25 Warner-Lambert Company Benzylidene-lactone and their thiocarbonyl analogs as inhibitors of proteoglycan degradation
GB9704499D0 (en) * 1997-03-05 1997-04-23 Glaxo Wellcome Spa Method of manufacture
CN103342672B (zh) * 2013-07-02 2015-12-23 扬州大学 取代吡咯烷-2-酮的新合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3714153A (en) * 1970-06-22 1973-01-30 Roussel Uclaf Novel cyclopropanecarboxylic acids
DE2329308A1 (de) * 1972-03-03 1975-01-02 Gruenenthal Chemie Neue lactame
AU518986B2 (en) * 1977-10-11 1981-10-29 Takeda Chemical Industries Ltd. Lactams
US4138495A (en) * 1978-05-19 1979-02-06 Stauffer Chemical Company N-Substituted pyrrolidones and their use as miticides
US4431656A (en) * 1981-02-05 1984-02-14 Kanegafuchi Chemical Industry Company Limited 3,5-di-Tert-butylstyrene derivatives, salts thereof, and pharmaceutical compositions containing the same as an active ingredient
JPS57130950A (en) * 1981-02-05 1982-08-13 Kanegafuchi Chem Ind Co Ltd 3,5-di-tert-butyl-4-hydroxystyrene derivative and anti- inflammatory, analgesic, antipyretic agent and inhibitor for blood platelet aggregation
JPS5879944A (ja) * 1981-11-09 1983-05-13 Kanegafuchi Chem Ind Co Ltd ３，５−ジ・タ−シヤリ−・ブチルスチレン誘導体及び抗炎症、鎮痛、解熱剤並びに血小板凝集阻害剤
US4440784A (en) * 1981-02-05 1984-04-03 Kanegafuchi Chemical Industry Company, Ltd. Anti-inflammatory, analgesic, and antipyretic pharmaceutical composition
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
JPS6112660A (ja) * 1984-06-27 1986-01-21 Kanegafuchi Chem Ind Co Ltd 新規２−ピロリドン誘導体及び抗炎症剤
JPH0623194B2 (ja) * 1985-03-23 1994-03-30 鐘淵化学工業株式会社 新規ラクタム誘導体及び抗炎症剤
JPS6412660A (en) * 1987-07-07 1989-01-17 Canon Kk Original reader
JP3611676B2 (ja) * 1996-06-24 2005-01-19 アサマ化成株式会社 パン生地の改良剤およびパンの製造方法

Also Published As

Publication number Publication date
JPS61257967A (ja) 1986-11-15
NO861820L (no) 1986-11-10
DE3681076D1 (de) 1991-10-02
FI84172C (fi) 1991-10-25
HUT43040A (en) 1987-09-28
FI861698A0 (fi) 1986-04-22
MX162717A (es) 1991-02-18
EP0204964A1 (en) 1986-12-17
EP0204964B1 (en) 1991-08-28
JPH066571B2 (ja) 1994-01-26
PT82540B (pt) 1988-08-17
CA1264762A (en) 1990-01-23
ES554775A0 (es) 1987-11-01
KR910004789B1 (ko) 1991-07-13
HUT45493A (en) 1988-07-28
HU199117B (en) 1990-01-29
AU581078B2 (en) 1989-02-09
CN1014058B (zh) 1991-09-25
ATE66673T1 (de) 1991-09-15
DK213286D0 (da) 1986-05-07
FI84172B (fi) 1991-07-15
KR860008973A (ko) 1986-12-19
US4833160A (en) 1989-05-23
PH23225A (en) 1989-06-06
HU196749B (en) 1989-01-30
CN86103227A (zh) 1987-01-21
ZA863352B (en) 1986-12-30
AU5676686A (en) 1986-11-13
PT82540A (en) 1986-06-01
NZ216092A (en) 1988-08-30
DK213286A (da) 1986-11-10
ES8800148A1 (es) 1987-11-01
FI861698A (fi) 1986-11-10

Similar Documents

Publication Publication Date Title
PH23189A (en) 2-pyrrolidone derivative
GR3024255T3 (en) Benzo-fused lactams
AU598213B2 (en) Certain N-substituted butyramide derivatives
EP0534396A3 (en) Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
DE69428703D1 (de) Pyrrolidin derivate
TW279858B (zh)
PH23068A (en) Novel nitromethylene derivatives
NZ233735A (en) Heterocyclic substituted aminophenol derivatives
ATE112558T1 (de) Glycosidasehemmer.
JPS5463086A (en) 33*22hydroxyy44*substituted*phenyl* azacycloalkane as analgesic*its derivative and intermediate
IE880061L (en) 1,2,4,5-tetrasubstituted benzene derivatives
GB9320785D0 (en) Dibenzylheterocyclic or dibenzylcycloalkyl derivatives as inhibitors of hiv intergrase
NO944075D0 (no) Fremgangsmåte for fremstilling av (S)-3-amino-1-substituert pyrrolidiner
ZA85624B (en) Indolophenathridines
EP0464359A3 (en) Process for the preparation of n-substituted pyrrolidones
DE2862361D1 (en) 3,4-methano pyrrolidine derivatives, compositions thereof and use as plant-growth regulating agents
FR2641170B3 (fr) Necessaire de cure pour personnes suivant en particulier des cures thermales
HU9500944D0 (en) N,n-substituted amino-methylen-imidazolinone derivatives as intermediates of 2-substituted 5-chloro-imidazol-4-carbaldeydes